Ilamycin C induces apoptosis and inhibits migration and invasion in triple-negative breast cancer by suppressing IL-6/STAT3 pathway

The EGR1–STAT3 Transcription Factor Axis Regulates α-MSH–induced Tyrosinase Gene Transcription in Melanocytes

(2019) Soon Young Shin et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Triple negative breast cancer in Asia: An insider’s view

(2018) Chao Wang et al.   CANCER TREATMENT REVIEWS

Flubendazole elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition

(2018) Eunhye Oh et al.   INTERNATIONAL JOURNAL OF CANCER

Control of triple-negative breast cancer using ex vivo self-enriched, costimulated NKG2D CAR T cells

(2018) Yali Han et al.   Journal of Hematology & Oncology

Triple-Negative Breast Cancers: Systematic Review of the Literature on Molecular and Clinical Features with a Focus on Treatment with Innovative Drugs

(2018) Anna Diana et al.   Current Oncology Reports

Loss of Wwox drives metastasis in triple-negative breast cancer by JAK2/STAT3 axis

(2018) Renxu Chang et al.   Nature Communications

GGNBP2 suppresses triple-negative breast cancer aggressiveness through inhibition of IL-6/STAT3 signaling activation

(2018) Jingjing Liu et al.   BREAST CANCER RESEARCH AND TREATMENT

Osthole inhibits triple negative breast cancer cells by suppressing STAT3

(2018) Xuanxuan Dai et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Universal CARs, universal T cells, and universal CAR T cells

(2018) Juanjuan Zhao et al.   Journal of Hematology & Oncology

STAT3 activation by leptin receptor is essential for TNBC stem cell maintenance

(2017) Praveena S Thiagarajan et al.   ENDOCRINE-RELATED CANCER

The Gαh-PLCδ1 signaling axis drives metastatic progression in triple-negative breast cancer

(2017) Shang-Pen Huang et al.   Journal of Hematology & Oncology

Emerging therapies for breast cancer

(2017) Xichun Hu et al.   Journal of Hematology & Oncology

Brevianamides and Mycophenolic Acid Derivatives from the Deep-Sea-Derived Fungus Penicillium brevicompactum DFFSCS025

(2017) Xinya Xu et al.   Marine Drugs

Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways

(2017) Sherif Abdelaziz Ibrahim et al.   Molecular Cancer

Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents

(2017) Junying Ma et al.   Nature Communications

Cytoglobosins H and I, New Antiproliferative Cytochalasans from Deep-Sea-Derived Fungus Chaetomium globosum

(2016) Zhihan Zhang et al.   Marine Drugs

Arctigenin inhibits STAT3 and exhibits anticancer potential in human triple-negative breast cancer therapy

(2016) Tingting Feng et al.   Oncotarget

Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells

(2015) Jaemoo Chun et al.   CANCER LETTERS

Cytotoxic and Antibacterial Angucycline- and Prodigiosin- Analogues from the Deep-Sea Derived Streptomyces sp. SCSIO 11594

(2015) Yongxiang Song et al.   Marine Drugs

The IL-6/JAK/Stat3 Feed-Forward Loop Drives Tumorigenesis and Metastasis

(2015) Qing Chang et al.   NEOPLASIA

Marketed Marine Natural Products in the Pharmaceutical and Cosmeceutical Industries: Tips for Success

(2014) Ana Martins et al.   Marine Drugs

STAT3 Target Genes Relevant to Human Cancers

(2014) Richard Carpenter et al.   Cancers

The role of intratumoral and systemic IL-6 in breast cancer

(2013) Christine Dethlefsen et al.   BREAST CANCER RESEARCH AND TREATMENT

Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells

(2013) Seog-Young Kim et al.   CELLULAR SIGNALLING

Fragment-based drug design and identification of HJC0123 , a novel orally bioavailable STAT3 inhibitor for cancer therapy

(2013) Haijun Chen et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Vimentin as a poor prognostic factor for triple-negative breast cancer

(2013) Nami Yamashita et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Strong association of fascin expression with triple negative breast cancer and basal-like phenotype in African-American women

(2013) Ashwini K Esnakula et al.   JOURNAL OF CLINICAL PATHOLOGY

Role of STAT3 in Cancer Metastasis and Translational Advances

(2013) Mohammad Zahid Kamran et al.   Biomed Research International

Overexpression of phospholipase D enhances Bcl-2 expression by activating STAT3 through independent activation of ERK and p38MAPK in HeLa cells

(2012) Hye-Jin Choi et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Interleukin-6 signaling pathway in targeted therapy for cancer

(2012) Yuqi Guo et al.   CANCER TREATMENT REVIEWS

Gold from the sea: Marine compounds as inhibitors of the hallmarks of cancer

(2011) Marc Schumacher et al.   BIOTECHNOLOGY ADVANCES

Vimentin in cancer and its potential as a molecular target for cancer therapy

(2011) Arun Satelli et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Marine natural products targeting phospholipases A2

(2010) Florence Folmer et al.   BIOCHEMICAL PHARMACOLOGY

Matrix Metalloproteinases: Regulators of the Tumor Microenvironment

(2010) Kai Kessenbrock et al.   CELL

The dark and the bright side of Stat3: proto-oncogene and tumor-suppressor

(2009) Andrea Ecker   Frontiers in Bioscience-Landmark

Clinical significance of matrix metalloproteinase 2 and 9 in breast cancer

(2009) PS Patel et al.   INDIAN JOURNAL OF CANCER

The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases

(2007) Paul et al.   Frontiers in Bioscience-Landmark

Fra-1 and Stat3 synergistically regulate activation of human MMP-9 gene

(2007) Yuhua Song et al.   MOLECULAR IMMUNOLOGY